Find a Tender
active
Official procurement procedure
Electronic Quality Management System (eQMS) for Medicines Discovery Catapult
IT services: consulting
software development
Internet and support
UK
Published value
£455,000
Submission deadline 7 Nov 2022, 15:00 GMT
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "Electronic Quality Management System (eQMS) for Medicines Discovery Catapult". Published status: active. Published value: £455,000. 1 published lot. Recorded submission deadline: 7 Nov 2022, 15:00 GMT. See the official notice for participation instructions.
| Contracting Authority | Medicines Discovery Catapult | Scope & Categories | Not published | Submission Window | Closed 7 Nov 2022, 15:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £455,000 |
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 4 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult | Procedure methodNot published | Procurement categoryNot published |
Statusactive | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published7 Oct 2022, 14:30 BST | Last source update7 Oct 2022, 14:30 BST | Recurring procurementNo |
ClassificationIT services: consulting, software development, Internet and support | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0373f4 | ||
What is being bought
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
MDC requires a robust Electronic Quality Management System (eQMS) to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC’s operations at large.
Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545
What changed
From the official release history
- Published value updated to £455,000
7 Oct 2022, 14:30 BST - Status changed to active
7 Oct 2022, 14:30 BST - Official notice release published
7 Oct 2022, 14:30 BST - Submission deadline changed to 7 Nov 2022, 15:00 GMT
7 Oct 2022, 14:30 BST - Buyer information updated
7 Oct 2022, 14:30 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedactivePublished valueNot publishedMedicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust eQMS to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC’s operations at large. An open procurement procedure is being used. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
7 Oct 2022, 14:30 BST - Submission deadline
7 Nov 2022, 15:00 GMT
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Medicines Discovery Catapult
Contracting authority GB-FTS-23690Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published